The transcriptional activator NRF2 is frequently activated in non-small cell lung cancer, and NRF2 overexpression results in the accumulation of CCAAT Enhancer Binding Protein Beta (CEBPB) [11]. Here, CEBPB is linked to non-small cell lung carcinoma.